Aging Research Group
Development of experimental animal models, securing and commercializing anti-aging core technologies, ensuring a stable supply of high-quality naturally aged mice, standardizing aging animal management, and establishing advanced research equipment and new analytical methods based on cells and bioimaging
- Discovery of anti-aging bioactive substances and functional materials
- Development of diagnostics and therapeutics for geriatric diseases based on real-time cell and bioanalysis technologies
- Securing core real-time imaging technologies and developing evaluation systems
- Development of animal models for geriatric diseases (fruit flies, zebrafish, mice)
- Standardization of aging animal models and establishment of a collaborative network based on the Korean Frailty Index (K-Frailty Index)
Research Infrastructure
Real-time 3D bioimaging analysis using In Vivo & In Vitro Micro-CT
| Core Experts |
Possesses Korea’s highest-level research capabilities in X-ray imaging and analysis
Principal Researcher Jae-Il Park, Engineer Hye-Yeon Jeong |
|---|---|
| Equipment Capabilities | Achieved world-class level in bioimaging research linked with Lab-CT |
| Potential Research Outcomes | Within the next five years, it is expected to secure breakthrough analytical technologies in the field of bioimaging by integrating Lab-CT with synchrotron accelerators and software. |
Real-time Cell and Bioanalysis using 3D Holo-Tomography
| Core Experts |
Possesses Korea’s highest-level research capabilities in the relevant field
Possesses Korea’s highest-level research capabilities in the relevant field |
|---|---|
| Equipment Capabilities | Achieved world-class level in disease cell research using 3D holo-tomography |
| Potential Research Outcomes | Within the next five years, it is expected to achieve more than 100% of the technology level of advanced countries in disease cell analysis research using 3D holo-tomography. |
Efficacy Verification of Geriatric Diseases Using Model Animals (Zebrafish)
| Core Experts |
Over 15 years of experience in evaluating the efficacy of new functional materials derived from natural products
Principal Researcher Gil-Nam Kim |
|---|---|
| Equipment Capabilities | Possesses analytical technologies for evaluating the functionality of natural products using high-performance flow cytometry |
| Potential Research Outcomes | Within the next five years, expected to publish more than 5 papers in the top 5% of JCR journals and file more than 2 technology patents |
Efficacy Evaluation Technology for Gut Microbiota in Various Diseases Using Animal Models (Mouse)
| Core Experts |
Possesses Korea’s highest-level research capabilities in microbiome multi-omics analysis
Principal Researcher Hye-Jong Jeong |
|---|---|
| Equipment Capabilities | Maintains a gut microbiota bank of 2,000 species through world-class absolute anaerobic microbial cultivation technology and optimized culture media |
| Potential Research Outcomes | Within the next five years, expected to publish at least 2 papers in the top 5% of JCR journals and file and register at least 3 technology patents |
Identification of the efficacy of bone metabolism, bone regeneration, and bone disease control through the development of bone differentiation and imaging analysis methods
| Core Experts |
Possesses Korea’s highest-level research capabilities in bone differentiation and bone disease analysis
Senior Researcher Kyung-Ran Park |
|---|---|
| Equipment Capabilities | Holds world-class bioimaging analysis methods related to bone diseases and secures biomaterials/biological efficacy factors for bone regulation |
| Potential Research Outcomes | Within the next five years, expected to publish at least 2 papers in the top 5% of JCR journals and file more than 2 technology patents |